Hyperthermic intraperitoneal chemotherapy for ovarian cancer: long-term findings from the OVHIPEC-1 trial
Lancet Oncol
.
2023 Oct;24(10):1057-1059.
doi: 10.1016/S1470-2045(23)00447-3.
Authors
Valentina Ghirardi
1
,
Anna Fagotti
2
,
Giovanni Scambia
3
Affiliations
1
Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy.
2
Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy; Universita' Cattolica del Sacro Cuore, Rome 00168, Italy.
3
Gynecologic Oncology, Fondazione Policlinico Universitario A Gemelli, IRCCS, Rome, Italy; Universita' Cattolica del Sacro Cuore, Rome 00168, Italy. Electronic address: giovanni.scambia@policlinicogemelli.it.
PMID:
37797627
DOI:
10.1016/S1470-2045(23)00447-3
No abstract available
Publication types
Clinical Trial
Comment
MeSH terms
Combined Modality Therapy
Cytoreduction Surgical Procedures
Female
Humans
Hyperthermia, Induced*
Hyperthermic Intraperitoneal Chemotherapy
Ovarian Neoplasms* / drug therapy